TELAN; Leila
Patent Applications and Registrations
Patent applications and USPTO patent grants for TELAN; Leila.The latest application filed is for "n-biarylamides".
- TELAN; Leila - Wuppertal DE
- Telan; Leila - Dusseldorf DE
| Patent | Date |
|---|---|
| N-biarylamides App 20180325878 - FLE NER; Timo ; et al. | 2018-11-15 |
| N-biarylamides Grant 9,867,812 - Fle.beta.ner , et al. January 16, 2 | 2018-01-16 |
| N-biarylamides App 20160310474 - Flebner; Timo ; et al. | 2016-10-27 |
| N-biarylamides Grant 9,227,964 - Fle.beta.ner , et al. January 5, 2 | 2016-01-05 |
| N-biarylamides App 20140288118 - Flebner; Timo ; et al. | 2014-09-25 |
| N-biarylamides Grant 8,691,840 - Flessner , et al. April 8, 2 | 2014-04-08 |
| Heterocyclic derivatives Grant 8,343,987 - Gielen-Haertwig , et al. January 1, 2 | 2013-01-01 |
| N-biarylamides App 20120157490 - FLE NER; Timo ; et al. | 2012-06-21 |
| I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use Grant 8,173,665 - Gielen-Haertwig , et al. May 8, 2 | 2012-05-08 |
| 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors Grant 8,101,615 - Gielen-Haertwig , et al. January 24, 2 | 2012-01-24 |
| Dihydropyridinone derivatives Grant 8,097,629 - Gielen-Haertwig , et al. January 17, 2 | 2012-01-17 |
| N-biarylamides Grant 8,030,329 - Flessner , et al. October 4, 2 | 2011-10-04 |
| Heterocyclic derivatives Grant 7,893,073 - Gielen-Haertwig , et al. February 22, 2 | 2011-02-22 |
| Substituted [(phenylethanoyl)amino]benzamides Grant 7,776,922 - Bruggemeier , et al. August 17, 2 | 2010-08-17 |
| Heterocyclic Derivatives App 20100184788 - GIELEN-HAERTWIG; Heike ; et al. | 2010-07-22 |
| Dihydropyridine derivatives for use as human neutrophil elastase inhibitors Grant 7,691,854 - Gielen-Haertwig , et al. April 6, 2 | 2010-04-06 |
| Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes Grant 7,687,510 - Gielen-Haertwig , et al. March 30, 2 | 2010-03-30 |
| I-pheny 1-3,4-dihydropyrimidin-2(1h)-one Derivatives And Their Use App 20100022537 - Gielen-Haertwig; Heike ; et al. | 2010-01-28 |
| 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use Grant 7,566,723 - Gielen-Haertwig , et al. July 28, 2 | 2009-07-28 |
| N-Biarylamides App 20080214602 - Flessner; Timo ; et al. | 2008-09-04 |
| Substituted [(Phenylethanoyl)Amino]Benzamides App 20080171786 - Bruggemeier; Ulf ; et al. | 2008-07-17 |
| N-biarylamides Grant 7,354,930 - Fle.beta.ner , et al. April 8, 2 | 2008-04-08 |
| 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors App 20080064704 - Gielen-Haertwig; Heike ; et al. | 2008-03-13 |
| Dihydropyridinone Derivatives App 20080045541 - Gielen-Haertwig; Heike ; et al. | 2008-02-21 |
| Heterocyclic Derivatives App 20080021053 - Gielen-Haertwig; Heike ; et al. | 2008-01-24 |
| Dihydropyridine derivatives for use as human neutrophil elastase inhibitors App 20070167406 - Gielen-Haertwig; Heike ; et al. | 2007-07-19 |
| Dihydropyridinone derivatives Grant 7,230,017 - Gielen-Haertwig , et al. June 12, 2 | 2007-06-12 |
| N-biarylamides App 20070112023 - Flessner; Timo ; et al. | 2007-05-17 |
| Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes App 20060160801 - Gielen-Haertwig; Heike ; et al. | 2006-07-20 |
| Heterocyclic derivatives App 20060111377 - Gielen-Haertwig; Heike ; et al. | 2006-05-25 |
| Dihydropyridinone derivatives App 20060100207 - Gielen-Haertwig; Heike ; et al. | 2006-05-11 |
| Tetrahydroquinoxalines acting as bradykinin antagonists App 20040235849 - Beyreuther, Bettina ; et al. | 2004-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 